← SynDRA
ML-141
SynDRA canonical compound SYN0062909 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | CDC42 |
|---|
| Mechanism of action | GTPase inhibitor |
|---|
Cross-references
Synonyms
- RefChem:912207
- ML141
- CID-2950007
- MFCD05987165
- MLS000693334
- MLS002699035
- KUC103352N-2
- SMR000299863
- QBNZBMVRFYREHK-UHFFFAOYSA-N
- MLS006011906
- orb1305451
- SCHEMBL12494043
- BDBM43220
- CHEBI:91613
- cid_2950007
- GLXC-02626
- HMS2688G07
- KUC103352N
- EX-A1165
- WCA20335
- KSC-6-125
- s7686
- SBB085162
- STL259581
- AKOS000296683
- AKOS022118974
- KUC103352N-03
- CCG-268734
- CS-3940
- KSC-23-233
- ML-141?
- Cdc42/Rac1 GTPase Inhibitor, ML141
- NCGC00263209-01
- NCGC00263209-02
- NCGC00263209-09
- NCGC00263209-12
- AC-33173
- AS-16658
- HY-12755
Look up ML-141 in the interactive SynDRA portal →